 |
BC24593 |
Rapamycin, 42-O-(2-hydroxyethyl)-, mixt. with 3-hydroxy-α-methyl-L-tyrosine |
1350905-84-8 |
C63H96N2O18 |
1169.4389 |
VIEW DETAILS > |
 |
BC37726 |
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-, mixt. with (R)-4-amino-3-isoxazolidinone |
37350-37-1 |
C46H64N6O14 |
925.0322 |
VIEW DETAILS > |
 |
AE40266 |
Ro 4-5127 Oxalic Acid Salt |
1246817-07-1 |
|
|
VIEW DETAILS > |
 |
BC52199 |
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-, mixt. with (6R-trans)-3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, [2S-(2α,5α,6β)]-6-[(carboxyphenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid and O-2-deoxy-2-(methylamino)-α-L-glucopyranosyl-(1→2)-O-5-deoxy-3-C-formyl-α-L-lyxofuranosyl-(1→4)-N,N′-bis(aminoiminomethyl)-D-streptamine |
142987-37-9 |
C97H131N15O36S3 |
2179.3519 |
VIEW DETAILS > |
 |
AH05915 |
Rifaprim |
61498-94-0 |
C57H76N8O15 |
1113.2579 |
VIEW DETAILS > |
 |
BC98939 |
Retinoic acid, mixt. with (11β,16α)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione |
63812-69-1 |
C42H57FO7 |
692.8962 |
VIEW DETAILS > |
 |
BD51103 |
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-, mixt. with O-2-deoxy-2-(methylamino)-α-L-glucopyranosyl-(1→2)-O-5-deoxy-3-C-(hydroxymethyl)-α-L-lyxofuranosyl-(1→)-N,N′-bis(aminoiminomethyl)-D-streptamine |
51602-35-8 |
C64H99N11O24 |
1406.5302 |
VIEW DETAILS > |
 |
BG25405 |
rel-N-[(4R,6R)-2-(Aminosulfonyl)-5,6-dihydro-6-methyl-7,7-dioxido-4H-thieno[2,3-b]thiopyran-4-yl]acetamide |
199734-58-2 |
|
|
VIEW DETAILS > |
 |
BD24057 |
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-, mixt. with (2S,2′S)-2,2′-(1,2-ethanediyldiimino)bis[1-butanol] and 4-pyridinecarboxylic acid hydrazide |
402507-77-1 |
C59H89N9O15 |
1164.3893 |
VIEW DETAILS > |
 |
BG25944 |
Retinoic acid, (9?,13-cis)- |
286464-92-4 |
|
|
VIEW DETAILS > |